The genus Pontibacter is a recent addition to the family Cytophagaceae, phylum Bacteroidetes. Previous reports of its cultivation and molecular detection are from a variety of environmental sources, including marine and desert habitats. We report the first description of a Pontibacter sp., which was initially identified as Elizabethkingia meningoseptica, isolated from a human clinical specimen. On the basis of 16S rRNA gene sequence, unique mass spectral profile and phenotypic characterization, this isolate represents a novel species within the genus Pontibacter that has been named Pontibacter altruii, sp. nov., strain Grand Forks.
Background
The phylum Bacteroidetes is an extremely large and diverse taxon composed of Gram-negative, non-sporulating, aerobic and anaerobic, rod-shaped bacteria. Among the many members of this phylum is the genus Pontibacter [1, 2] . Members of this genus, like most of their relatives, occupy a vast array of habitats that include soil (mud and desert), marine and freshwater environments; however, until now, human clinical isolates of Pontibacter have not been reported [2] . Here we report the isolation and characterization of a novel Pontibacter sp., the first isolate in the genus to originate from a human. This bacterium was the sole isolate from one of four blood culture specimens collected from a woman with apparent sepsis, who later recovered upon treatment with broad-spectrum antimicrobial therapy; however, the role of this organism in the patient's illness is unknown. Detailed below is the clinical case description, details of strain isolation, and characterization of Pontibacter altruii sp. nov., strain Grand Forks.
Case description
A 72-year-old woman presented to the emergency department of a local hospital in Grand Forks, ND, USA with complaints of increasing shortness of breath and was noted to be acutely confused and in respiratory and renal failure. The patient's past medical history was significant for hypertension, hyperlipidaemia, type 2 diabetes mellitus and chronic hypoxic respiratory failure. A computed tomography scan of the patient's torso revealed mediastinal lymphadenopathy and pulmonary nodule enlargement, mitral valve calcification, cholelithiasis and diffuse pulmonary interstitial thickening with ground-glass opacities consistent with possible interstitial pulmonary oedema secondary to congestive heart failure. A transthoracic echocardiogram showed possible vegetations on the mitral and tricuspid valves, but vegetations were not apparent by trans-oesophageal echocardiogram. The patient was admitted to the intensive care unit and was immediately prescribed empiric antimicrobial therapy for treatment of suspected pneumonia. On admission, blood cultures were collected by venipuncture and submitted in two paediatric blood culture bottles, documented as low-volume collections; a sputum culture was ordered, but was cancelled because a sputum specimen could not be procured. Results of tests for autoimmune diseases, influenza and disseminated fungal infections were all negative.
Following 72 h of incubation in a continuous monitoring blood culture system (BACTEC™ FX; BD Diagnostics, Sparks, MD), the aerobic culture vial (BD BACTEC™ Plus Aerobic/F) from one of two sets of blood cultures flagged positive. Microscopic examination of a Gram-stained smear of the blood culture broth revealed pleomorphic Gram-negative rods. Aliquots of the blood culture broth were subcultured to solid media, including sheep blood agar (tryptic soy agar containing 5% defibrinated sheep blood), chocolate agar and MacConkey agar (Remel, Lenexa, KS, USA). Following 24 h of incubation at 35°C in 5% CO 2 , a pure culture of small, white, smooth colonies grew on blood and chocolate agars, but no growth was noted on the MacConkey or other plates (Columbia CNA agar and anaerobe cultivation media). Gram-negative rods identical to those seen in the blood culture broth were observed in a Gram-stained smear of the colonial growth (Fig. 1) . The isolate tested positive for cytochrome oxidase and catalase, but tested negative for indole production using a spot indole testing procedure. Identification of the isolate was attempted by automated (VITEK ® 2 Gram-Negative Identification card; bioMérieux, Durham, NC, USA) and manual (API 20NE; bioMérieux) phenotypic methods, and automated (VITEK ® 2) testing was performed for preliminary antimicrobial susceptibility testing.
On admission, the patient started intravenous vancomycin (2000 mg on day 1, 1000 mg on day 2) and meropenem (500 mg/8 h). The patient stabilized overnight in the intensive care unit and was transferred to the general ward 17 h after admission. After 2 days of antibiotic treatment, vancomycin was discontinued due to elevated creatinine. The same day, a rash was observed and meropenem was switched to intravenous aztreonam (1 g/8 h) as the patient had a history of penicillin allergy. Following blood culture detection, but before susceptibility testing of the isolate, the patient also received intravenous levofloxacin (750 mg/48 h). During her inpatient stay, the patient also received warfarin, intravenous furosemide and bi-level positive airway pressure therapy for prevention of thromboembolism associated with atrial fibrillation, treatment of atrial fibrillation, hypertension and respiratory failure, respectively. On hospital day 17, she was switched to oral levofloxacin (750 mg/48 h for 10 days) and discharged to home in a stable condition. Two additional sets of blood cultures collected 1 day after the initial positive culture remained negative. At home, the patient was ordered to continue positive airway pressure therapy. To date, the patient is not known to have experienced a recrudescence of this infectious process.
Materials and methods

Morphological and physicochemical analyses
Morphological attributes of this isolate, including cell shape and size, were rendered from 1000× photomicrographs of Gramstained smears of colonial growth using an Olympus BX51 bright-field microscope equipped with a DP70 12-bit digital camera and Olympus cellSens software (Olympus, Waltham, MA, USA). Size measurements of 100 individual cells were made using IMAGEJ 1.X software [3] calibrated to the scale bar attached to the photomicrographs.
Following primary isolation, the isolate was subjected to automated phenotyping using the VITEK ® 2 Gram-Negative Identification card following the manufacturer's instructions for use. Briefly, colonies of the isolate were suspended in sterile 0.45% (w/v) non-bacteriostatic saline to create a cell suspension in the range of 0.5-0.63 McFarland units. Next, the suspension was applied, under vacuum, to a Gram-negative identification panel containing immobilized chromogenic substrates. Following incubation, the biochemical profile and presumptive identification were derived by the VITEK ® 2 software. In addition, the isolate was preliminarily identified using the API 20NE system. Characterization of the isolate using standard tubed biochemical media was later pursued, the results of which are listed in Table 1 . Antibiotic susceptibility testing Antibiotic susceptibility testing was performed using Etest (bioMérieux) and disc diffusion; testing was performed according to standard methods. Briefly, a suspension of bacterial colonies from a culture <24 h old were suspended in sterile 0.45% (w/v) non-bacteriostatic saline and the turbidity of the suspension was adjusted to match a 0.5 McFarland standard. Cation-adjusted Mueller-Hinton agar plates (150 mm; Remel, Lenexa, KS, USA) were subsequently inoculated with the suspension. When dry, either Etest strips or antibiotic-impregnated discs were applied with forceps, and inoculated plates were incubated at 35°C in an ambient atmosphere for 24 h.
Nucleic acid sequencing and mass spectrometry Total DNA was extracted from the isolate using a generic lysis and silica adsorption-based separation protocol (NucliSENS ® EasyMAG ® , bioMérieux; [4, 5] [7, 8] . Identification of the isolate was attempted by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry using a MALDI Biotyper instrument (BrukerDaltonics, Billerica, MA, USA); half of the spots were overlaid with 70% formic acid for on-target protein extraction [9] . Briefly, small portions of isolated colonies were smeared onto six separate spots on a 96-spot stainless steel MALDI-TOF target plate. Three of the spots were overlaid with 1 μl of 70% formic acid and allowed to completely dry. Next, all 6 spots were overlaid with 1 μl of matrix solution (α-cyano-4-hydroxycinnamic acid), dried and analysed. Each spot was lased 240 times to generate mass spectral profiles. Although mass peaks were recorded for all spots, no identification could be rendered from the MALDI Biotyper research use only library (BDAL, MBT Compass, 2016).
Phylogenetic analysis
The rRNA gene sequence derived from the isolate was used to construct a weighted neighbour-joining ('weighbour') tree employing Jukes-Cantor correction (100 bootstrapped replicates) [10] . The 16S rRNA gene sequence from the withinphylum organism Bacteroides fragilis (strain Bfr920) was used as the outgroup. The phylogenetic analysis was carried out using the Ribosomal Database Project (RDP) platform (rdp. cme.msu.edu) [11] .
Results
Clinical microbiology
After 3 days of incubation, one aerobic, paediatric vial from the two collected grew an unknown isolate on sheep blood and chocolate agars upon subculture. Primary phenotypic testing provisionally identified the organism as Elizabethkingia meningoseptica; however, low confidence scores for both VITEK ® 2-based and API 20NE-based identifications were obtained, prompting referral of the isolate to a commercial reference laboratory for definitive identification. The reference laboratory could not provide a species-level identification, but instead reported the isolate's identification as an unidentified Gramnegative rod, most common relative Pontibacter, based on partial 16S rRNA gene sequencing.
Colonial characteristics
The isolate grows moderately slowly on sheep blood and chocolate agars, but does not grow on Gram-negative selective media, including MacConkey agar, and fails to grow in anaerobic conditions. Pigment production, a prominent feature of other Pontibacter spp., was not demonstrable on sheep blood and tryptic soy agars following 7 days of incubation. Following 24 h of incubation, colonies are small (~1 mm), smooth and glistening ( Fig. 2A) . After 72 h at 35°C, colonies reach maximum size (Fig. 2B) . Following 96 h of incubation, a noticeable haze of growth emanating from the colonies is observable (Fig. 2C) , and is an indication of gliding motility, a form of motility described for other pontibacters [2] . Turbidity is seen in broth cultures after several days of incubation.
Phenotypic characterization
The isolate exhibits all defining phenotypes common to members of the genus Pontibacter, including morphology, Gram-stain reaction, gliding motility, strictly aerobic growth, cytochrome oxidase and catalase production. Biochemical parameters assessed and comparison to other Pontibacter spp. are listed in Table 1 .
Antimicrobial susceptibility testing
Antibiotic susceptibility testing demonstrated low MICs or large zones of inhibition surrounding most agents tested, except for the aminoglycosides amikacin, gentamicin and tobramycin ( Table 2 ).
Molecular characterization
The ribosomal RNA gene sequence showed 96% identity to Pontibacter rhizosphera and 95% identity to Pontibacter korlensis. Mass spectrum analysis of the isolate could not furnish an identification. The failure of both mass spectrometry and 16S rRNA gene sequencing to definitively identify the isolate suggested that it had not been previously characterized.
Phylogenetic analysis
Using weighted neighbour-joining methods, the isolate formed its own branch within the genus Pontibacter. The deepest branching species from the root was Pontibacter ruber, followed by a small group containing Pontibacter deserti and Pontibacter populi, which was followed by the novel isolate (Fig. 3) .
Discussion
Isolation of a novel member of the genus Pontibacter is described. Pontibacter spp. are known to occupy diverse habitats, but this is the first description of a Pontibacter sp. isolated from a human clinical specimen. Because all previous descriptions in the literature are from environmental sources (Table 3) , coupled with the fact that this isolate was only isolated from one of four blood culture vials, a criterion commonly used by clinical microbiology laboratories for defining blood culture contamination with host microbiota, the organism's pathogenic potential is unknown. In addition, direct testing of the patient's blood for this bacterium by methods such as PCR and next generation sequencing could not be performed, as the original blood specimens had already been discarded by the time such analyses were considered. The potential for this organism's misidentification through automated and manual, kit-based phenotypic testing platforms was exemplified in this report, as our isolate was identified as E. meningoseptica. In addition, the relatively recent designation of this genus suggests that Pontibacter spp. could have been isolated from other human infections in the past, but was given one or more misnomers. Many biochemical reactions are consistent with those of E. meningoseptica, but our isolate is indole negative, a characteristic that can be used to distinguish our isolate from E. meningoseptica. The data also highlight the need for confirming unusual identifications with additional methods, such as nucleic acid sequencing. This is, predictably, a relatively common scenario when commercially available microbial identification systems are challenged with rare and obscure taxa.
To the best of our knowledge, this is the first report of broad antimicrobial susceptibility profiling of a Pontibacter isolate. Although no categorical antimicrobial susceptibility interpretive guidelines exist for pontibacters, the MICs and zones of inhibition gleaned from in-depth testing shed some light on the susceptibility of this organism to a variety of antibiotic classes. For example, these data suggest either acquired or intrinsic resistance to aminoglycosides. This profile is consistent with that of other members of this genus, which also exhibit resistance to at least one member of the aminoglycosides [1, 2, 12] . However, MICs for most other antibiotics are low, suggesting that this isolate is susceptible to most routinely used antibiotics.
Ribosomal and phylogenetic analyses indicate that our isolate represents a novel species, and is appropriately assigned to the genus Pontibacter. The ribosomal RNA gene sequence and mass FIG. 3 . Phylogenetic analysis of the genus Pontibacter, including Pontibacter altruii sp. nov. A weighted neighbour-joining tree employing Jukes-Cantor correction (100 bootstrapped replicates) was generated using 16S ribosomal RNA gene sequence from 20 previously described Pontibacter species, P. altruii, sp. nov. and Bacteroides fragilis (outgroup). The position of P. altruii, sp. nov. (arrow) was somewhat ambiguous; however, it unambiguously clustered within the genus rather than creating a unique lineage. spectrum are unique to this organism. Its phylogenetic position based on 16S ribosomal RNA gene sequence indicates that it is a relatively divergent member of the genus, though not the most divergent. Based on these data, we propose the formal name P. altruii sp. nov., strain Grand Forks after the laboratory and geographic location of its isolation, respectively.
Conclusion and isolate naming
Description of P. altruii sp. nov., strain grand forks P. altruii sp. nov. (al tru' i i) N.L. neut. Of Altru Health System laboratory, the clinical laboratory responsible for recognizing the novelty of the species. Cells are Gram-negative, rod shaped, pleomorphic, and move by gliding motility. Aerobic. Nonsporulating. Chemoorganotroph. Acid is produced from lactose. Esculin, DNA and gelatin are hydrolysed. Catalase, oxidase and hydrogen sulphide are produced. Unique 16S rRNA gene sequence (GenBank Accession no. KX982528) distinct from the most closely related species in the genus Pontibacter. First isolated from the blood culture of a woman with sepsis in Grand Forks, North Dakota, USA. The type strain is Grand Forks.
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